In this work, the epidermal growth factor receptor (EGFR) is considered as a significant biomarker of the aggressive development of the tumor process, the overexpression of which is associated with accelerated division and proliferation of glioma cells (12). The gene discussed is EGFR; the disease is central nervous system cancer.